Jyy Fung

Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study

Safety of traditional Chinese medicine in patients with chronic hepatitis B is unknown.

Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection

Background  The efficacy of levofloxacin‐based quadruple therapy in resistant Helicobacter pylori infection is not known.

748 OUTCOME OF 4-YEAR TREATMENT OF ENTECAVIR FOR TREATMENT-NAIVE CHRONIC HEPATITIS B

This journal supplement is Abstract Book of the International Liver Congress 2011 by EASL (46th Annual Meeting)

Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B

Factors influencing changes in liver stiffness measurements during long‐term nucleoside analogue therapy for chronic hepatitis B (CHB) have not been thoroughly investigated.

Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.

Hepatic resection and radiofrequency ablation (RFA) are treatment options for early‐stage hepatocellular carcinoma (HCC). Whether tumour recurrence and long‐term survival favour either treatment has not been established. This randomized trial aimed to test the hypothesis that RFA is superior to hepatic resection in terms of lower tumour recurrence rate and better long‐term survival.

Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory-wide ecological study

The temporal relationship between nucleoside analogue therapy for chronic hepatitis B (CHB) and liver cancer development has not been evaluated at a population level.

Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection

We studied the intrahepatic hepatitis B virus (HBV) replicative status in 40 people with occult hepatitis B infection (OBI) and 40 patients with chronic hepatitis B (CHB). Intrahepatic HBV DNA, covalently closed circular DNA (cccDNA), and pre-genomic RNA (pgRNA) were quantified. Patients with OBI had median necroinflammation and fibrosis scores of 1 and 0, respectively. Intrahepatic total HBV DNA, cccDNA and pgRNA were detectable in 30 (77%), one (3%) and five (13%) of the participants with OBI, respectively. People with OBI had lower median intrahepatic total HBV DNA than the patients with CHB (p < 0.0001). They had nearly normal liver histology and low intrahepatic HBV replication.

Hepatitis B surface antigen levels predict minimal histologic changes in hepatitis B e antigen positive chronic hepatitis B

The 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012—Taipei, Taiwan—16–19 February

Hepatitis B virus serological and virological activities in blood donors with occult hepatitis B

23rd Annual Conference of APASL March 12–15, 2014, Brisbane, Australia Asian Pacific Association for the Study of the Liver 2014 Topic: 1 Acute Liver Failure

Elevation of ALT fails to predict significant histologic abnormalities in chronic hepatitis B patients

The 21st Conference of the Asian Pacific Association for the Study of the Liver